a Centre of Advanced Study in Crystallography and Biophysics, University of Madras , Guindy Campus, Chennai , India.
b Bioinformatics Infrastructure Facility , University of Madras , Guindy Campus, Chennai , India.
J Biomol Struct Dyn. 2018 Apr;36(5):1306-1328. doi: 10.1080/07391102.2017.1322004. Epub 2017 May 17.
Nicotinamide Phosphoribosyltransferase (NAMPT) is a rate-limiting enzyme in the biosynthesis of NAD. Cancer cells have elevated poly [ADP-Ribose] polymerase 1 (PARP) activity as well as the immense necessity of ATP: thereby consuming NAD at a higher rate than normal tissues. The perturbation of these intracellular processes is more sensitive and highly dependent on NAMPT to maintain the required NAD levels. Functional inhibition of NAMPT is, therefore, a promising drug target in therapeutic oncology. In this study, the importance of intermolecular contacts was realized based on contact occupancy and favorable energetic from molecular dynamic simulation to discern non-critical contacts of four different classes of potential NAMPT inhibitor bound complexes. Further, pharmacophore modeling, molecular docking, a quantum mechanical properties and MD simulation, as well as active site residual network communication were employed to identify potential leads. Present studies identified two leads, 2 and 3 which have better binding free energy compared to known inhibitors and showed stable hydrogen bonding and hydrophobic contacts with β barrel cavity lining residues in the active site of the dimer interface (A'B). Lead 2 containing fluorene as central core and lead 3 having phenyl-benzamide as a core showed stable moiety which was observed from electronic property analysis. Active site residual communication in identified leads bound complex also showed similarity to known inhibitor complexes. Compounds containing these moieties were not reported until now against NAMPT inhibition and can be considered as novel cores for future development of drugs to inhibit NAMPT function.
烟酰胺磷酸核糖基转移酶(NAMPT)是 NAD 生物合成中的限速酶。癌细胞的聚 [ADP-核糖] 聚合酶 1(PARP)活性升高,同时对 ATP 的需求量极大:因此,其消耗 NAD 的速度高于正常组织。这些细胞内过程的紊乱更为敏感,高度依赖 NAMPT 来维持所需的 NAD 水平。因此,功能性抑制 NAMPT 是治疗肿瘤学中一个很有前途的药物靶点。在这项研究中,基于分子动力学模拟的接触占有率和有利的能量,认识到了分子间接触的重要性,以区分四种不同类型潜在 NAMPT 抑制剂结合复合物的非关键接触。此外,还采用了药效基团建模、分子对接、量子力学性质和 MD 模拟以及活性位点残基网络通讯分析,以确定潜在的先导化合物。目前的研究确定了两个先导化合物 2 和 3,它们与已知抑制剂相比具有更好的结合自由能,并且在活性位点的二聚体界面(A'B)中与β桶腔衬里残基显示出稳定的氢键和疏水接触。含有芴作为中心核的先导化合物 2 和含有苯基苯甲酰胺作为核心的先导化合物 3 显示出稳定的部分,这是从电子性质分析中观察到的。在鉴定出的与先导化合物结合的复合物中,活性位点残基网络通讯也显示出与已知抑制剂复合物的相似性。到目前为止,还没有报道过含有这些部分的化合物对 NAMPT 抑制的作用,它们可以被认为是未来开发抑制 NAMPT 功能的药物的新型核心。